<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">18946342</PMID>
<DateCompleted>
<Year>2008</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1534-6080</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>86</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2008</Year>
<Month>Oct</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Transplantation</Title>
<ISOAbbreviation>Transplantation</ISOAbbreviation>
</Journal>
<ArticleTitle>Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience.</ArticleTitle>
<Pagination>
<MedlinePgn>1052-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0b013e3181874b06</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with human leukocyte antigen antibodies constitute a significantly disadvantaged population among those awaiting renal transplantation. We speculated that more understanding of the patients' antibody makeup would allow a more "immunologic" evaluation of crossmatch data, facilitate the use of virtual crossmatch (XM), and lead to more transplantability of these patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively compared the transplantability and transplant outcome of two consecutive patient populations transplanted in our center. Group I (n=374) was evaluated using solid-phase base testing for determination of percentage panel reactive antibody ("PRA screen") with limited antibody identification testing. Group II (n=333) was tested in a more comprehensive manner with major emphasis on antibody identification, antibody strength assignment, and the use of pronase for crossmatch.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Given this approach, 49% (166/333) of the transplanted patients in group II were sensitized compared with 40% (150/374) of the recipients in group I; P=0.012. Transplant outcome at 1-year posttransplant was similar in both groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We conclude that comprehensive evaluation of human leukocyte antigen sensitization and application of immunologic in analyzing compatibility between donor and recipient can increase the transplantability of sensitized patients while maintaining similar outcome. Our approach is in line with United Network for Organ Sharing new guidelines for calculated panel reactive antibody and virtual XM analysis. We hope this report will prompt additional transplant programs to consider how they will use the new United Network for Organ Sharing algorithms.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tambur</LastName>
<ForeName>Anat R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Division of Organ Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. a-tambur@northwestern.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leventhal</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kaufman</LastName>
<ForeName>Dixon B</ForeName>
<Initials>DB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Friedewald</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Joshua</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abecassis</LastName>
<ForeName>Michael M</ForeName>
<Initials>MM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK025243</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR025741</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Transplantation</MedlineTA>
<NlmUniqueID>0132144</NlmUniqueID>
<ISSNLinking>0041-1337</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007518">Isoantibodies</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000918">Antibody Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D002641">Chicago</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003141">Communicable Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003663">Decision Trees</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006084">Graft Rejection</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006085">Graft Survival</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019983">Guideline Adherence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006680">HLA Antigens</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006650">Histocompatibility Testing</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007114">Immunization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007518">Isoantibodies</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016030">Kidney Transplantation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017410">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014495">Universities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014584">User-Computer Interface</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>10</Month>
<Day>24</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>10</Month>
<Day>24</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">18946342</ArticleId>
<ArticleId IdType="doi">10.1097/TP.0b013e3181874b06</ArticleId>
<ArticleId IdType="pii">00007890-200810270-00007</ArticleId>
<ArticleId IdType="pmc">PMC4094141</ArticleId>
<ArticleId IdType="mid">NIHMS597683</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Am Soc Nephrol. 2001 Dec;12(12):2807-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11729251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2003 May 15;75(9):1601-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12792524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2003 Dec;3(12):1488-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14629279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 1985 Mar;39(3):316-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3975995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 1989 Nov;48(5):834-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2815255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2006 May 15;81(9):1331-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16699463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Immunol. 2006 Aug;67(8):597-604</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16916655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2006 Oct;6(10):2307-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16939516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2006 Dec 15;82(11):1524-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17164726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2007 Mar;7(3):626-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17352712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2007 Apr;7(4):1027-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17391143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2007 Apr;7(4):857-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17295642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Transpl. 2005;:259-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17424745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Transpl. 2006;:399-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18365396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tissue Antigens. 2005 Apr;65(4):370-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15787721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transpl Int. 1995;8(6):472-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8579739</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Transplant. 2006 Feb;10(1):38-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16499585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Immunol. 2005 Apr;66(4):343-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15866696</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>